Artal Group S.A. Repare Therapeutics Inc. Transaction History

Artal Group S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	BUY	$19.66 - $28.11 $2.95 Million - $4.22 Million	150,000 Added 27.27%	700,000 $14.8 Million
Q1 2021 May 14, 2021	SELL	$25.89 - $44.46 $517,800 - $889,200	-20,000 Reduced 3.51%	550,000 $16.9 Million
Q3 2020 Nov 13, 2020	SELL	$21.55 - $33.92 $646,500 - $1.02 Million	-30,000 Reduced 5.0%	570,000 $17.5 Million
Q2 2020 Aug 14, 2020	BUY	$30.8 - $32.99 $18.5 Million - $19.8 Million	600,000 New	600,000 $18.6 Million

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $55.4M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.